What is PT-141 (bremelanotide)?
What is PT-141, also called bremelanotide? Watch the full video above, or read the complete timestamped transcript below.
Transcript
[0:00] What is PT-141, also called bremelanotide?
[0:08] PT-141 is a synthetic peptide. It is a cyclic seven amino acid analogue of an older compound, melanotan 2. Both act on melanocortin receptors, a signalling family in the nervous system.
[0:17] It is studied in early phase and preclinical literature for centrally mediated effects, distinct from the vascular pathway that most erectile dysfunction drugs target. The published evidence sits in animal work and early human trials, not settled clinical practice.
[0:25] In the UK, PT-141 holds no marketing authorisation as a medicine. The MHRA does not assess research chemicals. It is sold legally only as a research chemical, research use only, not for human consumption.
[0:34] There is no UK approved patient information and no dosing guidance. Full evidence breakdown on peptideclear.co.uk/research-peptides.
[0:42] Full evidence breakdown on peptideclear.co.uk
Not medical advice. PeptideClear is editorial commentary only. Always consult a UK-registered healthcare professional.